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Abstract
Background: Numerous	 frameworks	 for	 supporting,	 evaluating	and	 reporting	patient	
and	 public	 involvement	 in	 research	 exist.	 The	 literature	 is	 diverse	 and	 theoretically	
heterogeneous.
Objectives: To	identify	and	synthesize	published	frameworks,	consider	whether	and	
how	these	have	been	used,	and	apply	design	principles	to	improve	usability.
Search strategy: Keyword	search	of	six	databases;	hand	search	of	eight	journals;	an‐
cestry	and	snowball	search;	requests	to	experts.
Inclusion criteria: Published,	systematic	approaches	(frameworks)	designed	to	sup‐
port,	evaluate	or	report	on	patient	or	public	involvement	in	health‐related	research.
Data extraction and synthesis: Data	were	extracted	on	provenance;	collaborators	
and	sponsors;	theoretical	basis;	lay	input;	intended	user(s)	and	use(s);	topics	covered;	
examples	of	use;	critiques;	and	updates.	We	used	the	Canadian	Centre	for	Excellence	
on	Partnerships	with	Patients	and	Public	(CEPPP)	evaluation	tool	and	hermeneutic	
methodology	to	grade	and	synthesize	the	frameworks.	In	five	co‐design	workshops,	
we	tested	evidence‐based	resources	based	on	the	review	findings.
Results: Our	final	data	set	consisted	of	65	frameworks,	most	of	which	scored	highly	on	the	
CEPPP	tool.	They	had	different	provenances,	intended	purposes,	strengths	and	limitations.	
We	grouped	them	into	five	categories:	power‐focused;	priority‐setting;	study‐focused;	re‐
port‐focused;	and	partnership‐focused.	Frameworks	were	used	mainly	by	the	groups	who	
developed	them.	The	empirical	component	of	our	study	generated	a	structured	format	and	
evidence‐based	facilitator	notes	for	a	“build	your	own	framework”	co‐design	workshop.
Conclusion: The	plethora	of	frameworks	combined	with	evidence	of	limited	transferabil‐
ity	suggests	that	a	single,	off‐the‐shelf	framework	may	be	less	useful	than	a	menu	of	evi‐
dence‐based	resources	which	stakeholders	can	use	to	co‐design	their	own	frameworks.
K E Y W O R D S
codesign,	framework,	hermeneutic	review,	patient	and	public	involvement,	systematic	review
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1  | BACKGROUND
It	is	a	truth	universally	acknowledged	by	policymakers,	researchers	
and	research	funding	bodies	that	patients	and	the	public	should	be	
“involved”	 in	 research,	 though	 there	 are	different	perspectives	on	
what	such	involvement	should	look	like	and	why	it	should	happen.	
Other	authors	have	summarized	a	diverse	literature	on	this	topic	(see	
in	particular	a	recent	BMJ	editorial1	and	these	theoretically	informed	
reviews2‐8).	In	sum,	three	main	arguments	prevail.
The	first	argument,	described	by	some	as	normative	and	others	
as	emancipatory,	holds	that	patients	have	a	right	to	have	an	input	
to	research	on	their	condition	and	that	reducing	the	known	power	
imbalances	between	researchers	and	patients	is	a	moral	duty	of	re‐
searchers,	especially	with	oppressed	and	seldom‐heard	groups.2‐4,9
The	 second,	 which	 some	 have	 described	 as	 consequentialist	
or	 efficiency‐oriented,3	 is	 that	 patient	 and	 public	 involvement,	 by	
bringing	 a	 real‐world	 and	 lived‐experience	 perspective,	 improves	
the	efficiency	and	value	of	 research	via	a	number	of	mechanisms:	
increasing	 its	 relevance	to	patients;	 improving	recruitment	and	re‐
tention	rates	of	research	participants;	extending	the	range	of	peo‐
ple	represented	in	research	studies;	and	improving	dissemination	of	
findings	 beyond	 academic	 audiences6,7,10,11—though	 the	 evidence	
base	for	all	these	claims	has	been	questioned.10,12
The	 third	 argument	 is	 political	 and	 practical:	 that	 forming	 alli‐
ances	with	patients	and	the	public	is	a	defining	feature	of	contem‐
porary	Mode	2	 science	 (in	which	 knowledge	 is	 co‐constructed	 by	
scientists	and	citizens,	often	beyond	the	walls	of	the	university13);	it	
increases	the	accountability	and	transparency	of	research	and	may	
be	an	effective	way	of	attracting	resources.5,10
Notwithstanding	 the	 different	 (and	 to	 some	 extent	 incom‐
mensurable)	 perspectives	 represented	 by	 the	 above	 literature,	
it	 is	 clear	 that	 improving	 patient	 and	 public	 involvement	 in	 re‐
search	 is	a	high	priority	for	research	policymakers,14‐16	research	
funders,17‐20	 researchers,21‐23	 some	 academic	 journals1	 and	 pa‐
tient	and	lay	organizations.24‐26	Many	of	these	groups	have	devel‐
oped,	or	are	in	the	process	of	developing,	structured	frameworks,	
tools,	 guidelines	 and	 checklists	 in	 an	 attempt	 to	 improve	 their	
own	performance	and	(in	some	cases)	critique	or	assess	the	per‐
formance	of	others.
As	a	multi‐stakeholder	research	collaboration	based	in	one	of	the	
UK's	 leading	medical	 and	 biotechnology	 research	 regions,	we	had	
a	strong	commitment	 to	strengthening	patient	and	public	 input	 to	
our	research.	When	we	began	this	study,	the	UK	National	Institute	
for	Health	Research	had	recently	put	out	for	consultation	its	draft	
benchmarks	for	patient	involvement	in	research.27	The	conditions	of	
our	funding	required	us	to	report	annually	on	our	patient	and	public	
involvement	activity.	We	sought,	therefore,	to	identify	one	or	more	
tools	or	frameworks	that	would	help	us	support,	evaluate,	improve	
and	report	on	the	patient	and	public	involvement	work	of	research	
teams	across	our	collaboration.
An	initial	browsing	search	identified	numerous	potential	frame‐
works	in	both	academic	and	grey	literature,	many	of	which	appeared	
to	have	been	carefully	researched	and	some	formally	validated	and	
field	 tested.	Different	groups	had	produced	different	 frameworks,	
drawing	on	different	principles,	applying	different	theories	and	pri‐
oritizing	different	potential	use	cases.	 It	was	clear	 that	developing	
a	 new	 framework	 from	 scratch	was	 almost	 certainly	 unnecessary,	
but	that	the	existing	 literature	could	benefit	from	a	taxonomy	and	
improved	accessibility.
Accordingly,	 we	 set	 out	 to	 achieve	 three	 objectives.	 First,	 to	
identify,	critically	examine,	summarize	and	synthesize	existing	tools,	
frameworks,	benchmarks,	guidelines	and	critical	appraisal	checklists	
for	patient	 and	 lay	 involvement	 in	 research.	 Second,	 to	determine	
which	of	the	frameworks	were	actually	used	and	why	(and	explain	
why	 others	 were	 not	 used).	 Third,	 to	 work	 with	 patient	 and	 lay	
groups	and	designers	to	adapt,	simplify	and	annotate	existing	frame‐
works	and	improve	their	aesthetic	appeal	and	usability.	As	the	study	
unfolded	 (and	 for	 reasons	 explained	 in	 the	 results	 section	 below),	
this	last	aim	evolved	to	incorporate	a	major	focus	on	optimizing	the	
process	of	running	workshops	aimed	at	generating,	adapting	and	op‐
erationalizing	 frameworks	for	 involving	 patients	 and	 lay	 people	 in	
research.
2  | METHOD
2.1 | Study design
Narrative	 systematic	 review,	 drawing	 on	 the	 principles	 of	 her‐
meneutic	 review,28	 along	 with	 lay	 consultation	 and	 co‐design.29 
Hermeneutic	 review	consists	of	 two	 interlinked	cycles	 (described	
in	more	detail	below):	 (a)	accessing	and	 interpreting	the	 literature	
and	(b)	developing	an	argument.	Searching	is	systematic	but	flexible	
and	 iterative.	As	sources	accumulate,	 it	becomes	necessary	to	 in‐
terpret,	clarify	and	understand	the	emerging	ideas	and	perspectives	
and	 to	 reject	 less	 relevant	 sources	 through	 progressive	 focusing.	
We	have	argued	elsewhere	that	narrative	review,	which	adds	suc‐
cessive	primary	studies	to	an	increasingly	rich	picture	of	a	complex	
field	of	study,	is	the	method	of	choice	for	synthesizing	and	making	
sense	of	a	large	and	diverse	body	of	primary	literature	where	differ‐
ent	groups	of	authors	have	approached	the	topic	in	very	different	
ways.30
2.2 | Data sources
We	searched	six	databases	(PubMed,	Embase,	Cinahl,	Social	Science	
Citation	Index,	Science	Citation	Index	and	PsycINFO)	to	end	2018	
using	the	following	concepts	and	key	words	(adapted	from	a	strat‐
egy	 used	 by	 previous	 authors31):	 (a)	 consumer	 or	 community	 or	
patient	 or	 citizen	 or	 user	 or	 lay	 or	 public	 or	 stakeholder;	 (b)	 par‐
ticipate	or	engage	or	involve	or	consult	or	empower	or	collaborate	
or	 inform;	 (c)	 health	 or	 medical	 or	 biomedical	 or	 nursing;	 (d)	 re‐
search	 or	 evaluation;	 (e)	 tool	 or	 toolkit	 or	 framework	 or	 guideline	
or	checklist.	We	hand‐searched	eight	journals	(Health Expectations,	
BMC Research Involvement and Engagement,	 International Journal of 
Consumer Studies,	 International Journal of Technology Assessment in 
Health Care,	Health Research Policy and Systems,	BMC Health Services 
     |  3GREENHALGH Et AL.
Research,	International Journal of Healthcare Quality Assurance and 
BMJ Open)	from	January	2008	to	December	2018.
We	also	searched	selected	grey	literature	sources	(eg,	guidance	
produced	 by	 national	 and	 international	 patient	 organizations	 and	
advocacy	groups,	health	services	or	think	tanks),	collated	sources	al‐
ready	known	to	the	authors	and	put	out	requests	to	our	professional	
networks	 (including	 social	 media	 followers).	 When	 we	 identified	
papers	 that	met	 our	 inclusion	 criteria,	we	 checked	 the	 references	
of	those	papers	and	also	put	the	title	into	Google	Scholar	to	subse‐
quent	citations	of	it	(an	“ancestry	and	snowball”	approach32).	Where	
papers	 cited	 a	 specific	 theoretical	 underpinning,	 we	 obtained	 the	
original	paper	describing	that	theory.	 If	a	framework	had	been	de‐
scribed	in	both	academic	and	grey	 literature,	we	included	only	the	
former.
2.3 | Inclusion and exclusion criteria
We	included	any	published,	systematic	approach	designed	to	inform,	
evaluate	or	 report	on	patient	and	public	 involvement	 in	health‐re‐
lated	research.	There	were	no	language	restrictions.	The	main	exclu‐
sion	criteria	were	as	follows:	not	a	 framework,	not	about	research	
or	lacking	provenance	(ie,	unable	to	trace	 its	source).	We	excluded	
frameworks	that	were	focused	only	on	communication	or	engage‐
ment	 (defined	 as	 explaining	 research	 to	 the	public)	 as	 opposed	 to	
involvement	(involving	patients	and	the	public	in	some	way	in	plan‐
ning,	undertaking	and	disseminating	research).	Largely	for	practical	
purposes,	grey	 literature	was	 limited	 to	publications	 from	national	
or	 international	 organizations	 (eg,	 James	 Lind	 Alliance,	 INVOLVE,	
Canadian	Institute	for	Health	Research).
2.4 | Data extraction and appraisal of quality
We	used	 an	 Excel	 spreadsheet	 to	 summarize	 key	 aspects	 of	 each	
study	 (both	 theoretical	 and	 empirical).	 For	 each	 framework,	 data	
were	extracted	on	the	rationale	for	its	development;	provenance	(in‐
cluding	funding/sponsorship);	patient/public	input;	theoretical	basis	
(if	any);	orientation	(initially	using	the	taxonomy	set	out	in	the	back‐
ground	above:	“emancipatory,”	“efficiency‐focused”	and	“practical,”	
and	evolving	as	new	categories	emerged);	fields	and	topics	covered;	
format	and	accessibility;	 intended	user(s)	and	purpose(s);	examples	
of	use;	and	critiques.	Three	reviewers	(TG,	AM	and	LH)	undertook	
data	extraction;	each	study	was	looked	at	by	two	reviewers	with	dis‐
agreements	resolved	by	discussion.	We	attempted	to	contact	 lead	
authors	of	all	papers	to	ask	whether	and	by	whom	the	framework	
had	been	used	since	its	publication.
Using	 data	 from	 these	 domains,	 we	 applied	 the	 Canadian	
Centre	for	Excellence	on	Partnerships	with	Patients	and	the	Public	
(CEPPP)	 evaluation	 tool,	which	 assesses	 four	 aspects	 of	 a	 tool	 or	
framework23:
•	 scientific	rigour	(graded	as	3	=	good,	2	=	moderate	or	1	=	weak);
•	 incorporation	of	patient/public	perspective	(graded	as	3	=	exten‐
sive,	2	=	limited,	1	=	absent	or	not	reported);
•	 comprehensiveness	 (graded	 as	 3	=	good,	 covering	 all	 intended	
dimensions;	 2	=	limited,	 covering	 only	 some	 key	 dimensions;	
1	=	very	limited);	and
•	 usability	 (graded	as	3	=	good,	extensive	evidence	of	use	beyond	
the	study	 in	which	 it	was	developed;	2	=	emerging	 [for	 recently	
published	frameworks	with	some	evidence	of	use];	1	=	limited	or	
unknown).
2.5 | Analysis and synthesis of primary literature
Using	 the	 iterative	 hermeneutic	methodology	 developed	 by	 Boell	
and	Cecez‐Kecmanovic,28	we	built	an	overall	picture	of	 the	differ‐
ent	kinds	of	frameworks	and	their	strengths	and	limitations,	adding	
detail	and	nuance	as	successive	studies	were	incorporated.
As	 an	 example	 of	 our	 approach,	 our	 hand	 search	 turned	 up	 a	
paper	by	Staniszewska	et	al33	on	the	GRIPP1	(Guidance	for	Reporting	
Involvement	of	Patients	and	Public)	framework	for	structuring	how	
researchers	 report	 lay	 involvement	 in	a	clinical	 trial.33	Through	ci‐
tation	tracking	of	 that	paper,	we	 identified	a	number	of	additional	
“report‐focused”	 frameworks,34‐36	 including	 GRIPP2.34	 Whilst	 we	
initially	 grouped	 all	 these	 as	 a	 subset	 of	 frameworks	 designed	 for	
planning	 and	 organizing	 patient	 involvement	 in	 research	 studies	
(“study‐focused”),	detailed	analysis	 revealed	that	these	were	sepa‐
rate	categories	with	limited	cross‐referencing	between	them.
We	 synthesized	 a	 preliminary	 set	 of	 resources	 based	 on	 the	
frameworks	 in	 our	 data	 set.	 To	 inform	 the	 practical	 workshops,	
rather	than	reproduce	all	the	frameworks	(since	many	covered	sim‐
ilar	ground),	we	worked	with	 lay	colleagues	 to	 select	 the	 “best‐in‐
class”	from	different	categories	in	our	data	set.	In	this	process,	we	
were	 guided	 by	 three	 questions:	 (a)	 did	 the	 framework	 score	well	
using	the	CEPPP	tool	(see	above)?	(b)	does	it	make	sense	to	patients	
and	lay	people	as	well	as	researchers—and	is	it	potentially	usable	by	
both?	and	(c)	will	it	allow	valid	measurement	and	iterative	improve‐
ment	of	patient	and	public	involvement	work	by	research	teams?
2.6 | Co‐design phase
We	shared	our	preliminary	set	of	12	“best‐in‐class”	resources	in	two	
preliminary	2‐hour	development	workshops	attended	by	a	total	of	
16	participants	recruited	from	three	local	pre‐existing	academic‐lay	
research	 partnerships	 (including	 researchers,	 patient	 involvement	
leads,	patients,	 carers	and	advocates).	We	adapted	 the	 interactive	
and	participatory	methodology	described	by	previous	authors.29,37 
Prior	to	the	first	workshop,	we	made	large‐scale	diagrams	of	the	dif‐
ferent	 “best‐in‐class”	 frameworks	 from	our	 systematic	 review	 and	
invited	the	groups	to	talk	about	them	and	use	sticky	notes	to	anno‐
tate	them.	We	systematically	captured	and	incorporated	their	sug‐
gestions	for	adaptation,	and	sought	input	from	a	professional	design	
service	to	produce	resources	in	multiple	formats.
The	 workshop	 materials,	 suggested	 format,	 resources	 and	 fa‐
cilitator	notes	produced	 in	 the	 two	development	workshops	were	
refined	 through	 three	 further	 pilot	workshops	 in	 contrasting	 clin‐
ical	 and	 research	 settings:	 a	 long‐established	patient	 participation	
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group	for	a	specialist	research	group	in	blood	disorders;	a	recently	
established	lay	partner	group	for	a	community‐based	mental	health	
research	 programme;	 and	 an	 academic‐lay‐industry	 partnership	
seeking	to	establish	working	principles	and	evaluation	methods	for	
lay	 participation	 in	 industry‐led	 clinical	 trials.	 Full	 details	 of	 these	
workshops	will	be	presented	in	a	separate	paper.
3  | RESULTS
3.1 | Description of data set
The	 study	 flow	 chart	 is	 shown	 in	 Figure	 1.	Of	 over	 5000	 titles,	
150	papers	were	retrieved	in	full	text;	this	sample	was	extended	
to	 250	 using	 ancestry	 and	 snowball	 searches.	 After	 applying	
exclusion	 criteria,	 our	 final	 data	 set	 consisted	 of	 64	 papers	 de‐
scribing	 65	 frameworks	 from	10	 countries	 (one	 paper	 described	
two	frameworks35):	UK	 (34	papers5,12,27,33‐36,38‐64),	United	States	
(14	 papers10,65‐77),	 Canada	 (7	 papers20,78‐83),	 Netherlands	 (3	 pa‐
pers84‐86)	and	one	paper	each	from	Australia,31	Spain,87	Zambia,88 
a	WHO	 consortium	 led	 from	 Switzerland,89	 a	 Southern	 African	
consortium	 led	 from	 South	 Africa90	 and	 a	 European	 consortium	
led	from	Belgium.91
The	 included	 publications	 described	 toolkits,	 tools,	 frame‐
works,	 checklists,	 benchmarks	 or	 maps	 for	 informing,	 guiding,	
assessing	or	 reporting	on	patient	and/or	public	 involvement	 in	 re‐
search.	A	 total	of	56	 frameworks	were	written	up	 in	55	academic	
papers.5,10,12,31,33‐36,38‐45,47‐50,52,53,55‐57,60‐67,69‐84,87‐90,92	Of	these,	44	
were	available	open	access.	Nine	frameworks	were	in	the	grey	litera‐
ture,	all	of	which	were	publicly	available.20,27,46,51,54,58,68,85,91
The	data	extraction	and	scoring	spreadsheet	for	the	65	frame‐
works	is	available	from	the	authors.	Almost	all	frameworks	in	our	
sample	 scored	moderately	 or	 very	 highly	 on	 the	CEPPP	 tool	 for	
scientific	rigour	(our	scoring	acknowledged	a	wide	range	of	study	
designs).	Most	frameworks	had	been	developed	using	a	systematic	
approach	with	substantial	input	from	patients	or	lay	people,	though	
approaches	used	varied	considerably.	Some	groups	had	used	pri‐
mary	qualitative	research50,55‐57,81,84	and/or	qualitative,	thematic	or	
narrative	literature	review,5,10,33‐35,39‐42,44,47,58,62‐64,70,74,76,81,82,85,87 
realist	 review	 (asking	 “what	 works	 for	 whom	 in	 what	 cir‐
cumstances”),48,79,80	 a	 consensus‐building	 process	 such	 as	
Delphi34,38,52,58,69	 or	 economic	 modelling.71	 Other	 frameworks	
had	been	developed	in	a	more	pragmatic	way	by	working	groups	
(typically	 involving	 lay	 people,	 researchers	 and/or	 research	
funders)	 with	 extensive	 consultation	 but	 without	 an	 in‐depth	
review	 of	 the	 relevant	 academic	 literature.20,27,36,59,69,78,91	 Some	
groups	 used	 a	 combination	 of	 literature	 review,	 qualitative	 re‐
search	 and	 workshops.31,34,53,58,65,72,73,75,77,80‐82,85,88,89	Some	
covered	 all	 lay	 involvement;	 others	 were	 restricted	 to	 specific	
groups	such	as	older	people,61,80	those	with	a	specific	clinical	con‐
dition,36,59,72,75,84,87	those	with	or	at	risk	of	a	genetic	condition72,85 
or	underserved	or	marginalized	groups.65,69,76,77,79	Most	grey	liter‐
ature	frameworks	gave	limited	details	of	methodology,	though	one	
drew	on	academic	sources91	and	two	described	and	referenced	a	
literature	review.46,54
Four	papers	proposed	a	“framework	of	frameworks”	taxonomy	
of	approaches	to	patient	and	public	involvement	in	research	(see	
Discussion	for	details).62‐64,83	The	remaining	61	frameworks	could	
be	grouped	into	five	main	categories	(though	several	had	features	
of	more	than	one):
1.	 Power‐focused:	 designed	 to	 surface,	 explore	 and	 overcome	
researcher‐lay	 power	 imbalances;
2.	 Priority‐setting:	 designed	 to	 involve	 patients	 and	 lay	 people	 in	
setting	research	priorities;
F I G U R E  1  Study	flow	chart
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3.	 Study‐focused:	designed	to	maximize	recruitment	and	retention	
to	clinical	trials	(and,	less	commonly,	other	study	designs),	thereby	
improving	the	quality	and	efficiency	of	research	and/or	maximiz‐
ing	its	societal	impact;
4.	 Report‐focused:	 designed	 to	 guide	 writing	 up	 and	 critical	 ap‐
praisal	of	research	reports;
5.	 Partnership‐focused:	designed	to	assure	transparency	and	public	
accountability	in	researcher‐lay	collaborations.
In	the	first	and	last	of	these,	the	presumed	unit	of	analysis	was	
a	partnership	(actual	or	desired).	In	the	middle	three,	the	presumed	
unit	 of	 analysis	 was	 a	 research	 study	 (usually,	 a	 clinical	 trial).	 In	
Table	1,	we	summarize	the	features	of	the	five	categories	of	frame‐
work,	highlighting	the	ones	we	selected	as	“best	in	class”	(high	score	
on	CEPPP	tool	and	liked	by	our	patient	advisers).	Below,	we	describe	
the	frameworks	in	each	category	in	more	detail,	giving	one	example	
of	each.	The	other	“best	in	class”	frameworks	are	reproduced	in	the	
Appendix	S1.
The	number	of	publications	per	year	 in	our	sample	 is	shown	in	
Figure	2.	Despite	there	being	no	date	limit	on	our	database	search,	
no	 frameworks	 had	 been	 published	 before	 2003.	 Since	 then,	 the	
number	published	annually	has	grown	steadily.	There	has	been	a	re‐
cent	steep	rise	in	the	publication	of	study‐focused	and	partnership‐
focused	frameworks	and	(in	2018)	reviews	of	frameworks.
3.2 | Power‐focused frameworks
Thirteen	 frameworks	 (eight	 from	 UK5,39‐45	 and	 five	 from	 United	
States65‐67,76,77)	were	developed	by	academically	 led	 teams	whose	
primary	interest	was	studying	and	challenging	power	differentials	in	
researcher‐lay	partnerships.	They	applied	theories	from	critical	so‐
ciology	such	as	Foucault	(who	proposed	that	knowledge	and	power	
are	 intimately	 related),	 Habermas	 (who	 explored	 the	 concealed	
power	games	between	those	based	in	the	“system”	and	those	out‐
side	it)	or	Bourdieu	(who	wrote	about	different	kinds	of	social	and	
cultural	capital,	of	which	specialized	knowledge	is	one	component),	
or	from	critical	public	health	(notably,	theories	of	power‐sharing	in	
community‐based	participatory	research).
Whilst	power‐focused	frameworks	addressed	similar	domains	
to	 those	 in	 other	 categories	 in	 our	 taxonomy,	 they	 asked	 more	
TA B L E  1  Taxonomy	of	frameworks	for	supporting	and	evaluating	patient	and	public	involvement	in	research
Category with selected “best in 
class” examples Main focus of frameworks in this category Comment
Power‐focused frameworks 
Oliver	et	al44 
Morrow	et	al42 
Gibson	et	al40 
Gradinger	et	al41 
Belone	et	al65
Conceptualizing,	surfacing	and	challenging	power	
differentials	between	researchers	and	patients/lay	
people 
Ethical	principles	for	such	power‐sharing 
Community‐based	participatory	research	(CBPR)	applies	
a	power‐focused	lens	to	researching	marginalized	or	
seldom‐heard	communities
Tend	to	be	academically	led,	richly	theorized	
and	emancipatory	in	ethos.	They	have	
informed	and	underpinned	more	pragmatic,	
partnership‐focused	frameworks	developed	
subsequently
Priority‐setting frameworks 
Viergever	et	al89 
Pollock	et	al36
Principles	and	methods	for	involving	patients	and	lay	
people	in	setting	research	priorities.	Includes	using	a	
structured	and	transparent	process;	ensuring	diversity	
of	participants;	providing	background	evidence;	
involving	technical	and	topic	experts;	and	translating	
priority	issues	into	researchable	questions
James	Lind	Alliance	(UK)	and	Patient‐
Centered	Outcomes	Research	Institute	
(USA),	for	example,	promote	priority‐setting	
partnerships	between	researchers	and	lay	
people
Study‐focused frameworks 
Evans	et	al48 
Shippee	et	al70 
NIHR	Research	Design	Service51 
Dillon	et	al73
Principles	and	methods	for	involving	patients	and	lay	
people	in	conducting	research,	especially	trials.	They	
follow	the	research	cycle	from	grant	application	to	
disseminating	findings	and	achieving	impact.	Most	cover	
building	a	culture	of	involvement,	attending	to	local	
context,	input	from	a	senior	leader,	developing	
relationships	and	trust,	ensuring	representativeness,	
training	and	capacity‐building,	and	facilitation
Most	study‐focused	frameworks	include	
limited	theory	but	Evans	et	al,	for	example,	
use	a	realist	approach	to	explore	link	
between	context,	mechanism	and	outcome
Report‐focused frameworks 
Stanislavska	et	al34 
Pollock	et	al53
Reporting	guidelines	for	writing	up	how	patient	and	
public	involvement	was	approached	in	a	research	study
Stanislavska	addresses	primary	research	(eg,	
trials);	Pollock	addresses	systematic	reviews
Partnership‐focused frameworks 
Boote	et	al38 
Baines	et	al60 
INVOLVE54 
De	Wit	et	al84 
Canadian	Institute	of	Health	
Research20 
Patient‐Focused	Medicines	
Development91
Particular	emphasis	on	demonstrating	what	measures	are	
in	place	to	support	the	academic‐lay	partnership	and	
provide	an	audit	trail	to	account	for	its	activities.	Focus	
is	on	governance	structures	(eg,	co‐chairing),	public	
release	of	data	(transparency),	communication	
processes	(eg,	showing	that	researchers	have	responded	
to	comments)	and	training	(of	both	researchers	and	
patients)
Frameworks	in	this	category	tend	to	link	a	
specific	value	or	principle	with	a	particular	
set	of	metrics	of	involvement	and	impact
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radical	questions.	They	were	particularly	interested,	for	example,	
in	surfacing	power	imbalances,	values	and	hidden	motives.	For	ex‐
ample,	they	did	not	merely	talk	about	“empowering”	patients	and	
lay	people;	they	asked	questions	such	as	“who	gets	to	define	what	
empowerment	 is?”	 and	 “whose	 interests	 are	 served	by	 so‐called	
empowerment?”
The	earliest	power‐focused	 framework	 in	our	data	 set	was	 led	
by	 Oliver's	 group	 at	 the	 Institute	 of	 Education.	 It	 was	 published	
in	 200444	 and	 updated	 in	 200839	 (see	 Appendix	 S1	 for	 diagram).	
Drawing	on	Arnstein's	ladder	of	participation,	they	rated	lay	input	on	
a	continuum	from	none	to	consultation	to	collaboration	to	control93; 
they	also	used	Mullen's	distinction	between	proactive	and	reactive	
behaviour	by	researchers	(researchers	could	invite	lay	groups,	invite	
individuals,	respond	to	lay	action	or	do	little	or	nothing).94	Oliver	et	
al5	 subsequently	updated	and	extended	 this	 framework	 further	 to	
include	 drivers	 for	 involving	 patients	 and	 public	 (why	 researchers	
invite	involvement;	why	people	get	involved);	processes	of	involve‐
ment	(how	people	are	brought	together,	how	they	interact);	and	the	
impact	of	involvement	(public	engagement	with	and/or	influence	on	
science).
Morrow	 et	 al42	 developed	 a	 Quality	 Involvement	 Framework	
based	on	Foucauldian	notions	of	power	and	depicting	both	a	user	
perspective—what	 was	 the	 individual	 able to do	 (eg,	 access	 re‐
sources);	what	 could	 they	potentially do	 (eg,	 apply	 for	 a	 role);	 and	
what	did	they	feel	(eg,	valued,	empowered,	conscious	of	power	dy‐
namics)—and	 a	 corresponding	 research	 context	 perspective—com‐
prising	research	relationships,	ways	of	doing	research	and	research	
structures	(see	Appendix	S1	for	full	questionnaire).
Prainsack,	 whose	 theoretical	 starting‐point	 was	 the	 “open‐
ing‐up”	 of	 science	 proposed	 by	 sociologists	 of	 science	 such	 as	
Nowotny,95	worked	with	 various	 genetics	 alliances	 to	 produce	 a	
set	of	six	principles	for	genetic	research;	many	of	the	questions	are	
framed	explicitly	 in	terms	of	power	 (“who	sets	the	agenda?”;	 “by	
whom	is	it	decided	what	good	outcomes	are?”;	“who	has	access	to	
what	data?”).43
Power‐focused	 frameworks	 exploring	 the	 values	 and	 eth‐
ical	 principles	 of	 lay	 involvement	 in	 research	 (see	 examples	 in	
Appendix	S1)40,41,45	appear	to	have	informed	the	subsequent	de‐
velopment	 of	 more	 pragmatic,	 partnership‐focused	 frameworks	
(discussed	below).
Some	 publications	 addressed	 researcher‐community	 power	
differentials	 through	 the	 lens	 of	 community‐based	 participa‐
tory	 research,65‐67,76	 including	 a	 comprehensive	 framework	 syn‐
thesized	 from	 earlier	 literature	 by	 Belone	 et	 al65	 (reproduced	 in	
Appendix	S1).	This	considered	contexts	(eg,	socio‐economic,	pol‐
icy,	institutional,	historical),	group	dynamics	(structural,	individual	
and	relational),	the	nature	of	the	intervention	and/or	research	(eg,	
cultural	fit,	partnership	synergy,	appropriateness	of	study	design)	
and	outcomes	(in	relation	to	both	individual	and	community	health	
and	the	wider	system,	including	capabilities,	power	relations	and	
“cultural	renewal”).
Two	 recent	 frameworks	were	 published	 from	 the	US	 Patient‐
Centered	 Outcomes	 Research	 Institute	 (PCORI),	 an	 arms‐length	
government	 organization	 (and	 leading	 funder	 of	 patient	 involve‐
ment	 research)	whose	main	 goal	 is	 ensuring	 that	 comparative	 ef‐
fectiveness	 studies	 address	 outcomes	 relevant	 to	 patients.	 One	
paper	described	a	framework	for	extending	such	research	with	the	
principles	of	community‐based	participatory	research,	with	a	view	
to	 building	 relationships	 with	 underserved	 communities.76	 This	
framework	emphasizes	using	assets‐based	rather	than	deficit	mod‐
els	to	assess	and	extend	community	capacities	and	embracing	an‐
thropological	as	well	as	biomedical	perspectives	on	the	causes	and	
management	of	illness.	The	other	paper	described	a	power‐focused	
framework	 for	 guiding	 the	 involvement	 of	 poor	 and	 underserved	
populations	in	research	using	routinely	collected	data	from	patient	
health	records.77
F I G U R E  2  Number	of	frameworks	on	
patient	and	lay	involvement	in	research	
published	annually	(includes	academic	and	
grey	literature)
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3.3 | Priority‐setting frameworks
Eight	 frameworks,	 from	 Canada,78	 Netherlands,86	 Switzerland,89 
UK,36,46 Zambia88	and	United	States,68,69	summarized	guidance	for	
a	structured	process	to	help	ensure	that	patients	and	lay	people	are	
involved	 (along	 with	 clinicians	 and	 researchers)	 in	 deciding	 which	
topics	to	prioritize	for	future	research.
In	2003,	Lomas	et	al78	published	the	output	of	a	Canadian‐UK	
health	 services	 research	 collaboration.	 Based	 on	 two	 extensive	
consultation	exercises	in	the	respective	countries,	they	proposed	
a	six‐step	approach:	identify	stakeholders;	identify	and	assemble	
any	data	needed;	design	and	complete	the	consultation,	bringing	
together	lay	partners	as	well	as	people	with	knowledge	(technical	
working	group)	and	people	with	power	(decision‐makers);	validate	
the	 identified	 priority	 issues	 against	 other	 sources	 of	 similar	 in‐
formation;	 translate	 priority	 issues	 into	 researchable	 topics	 and	
themes;	and	return	to	validate	the	priority	research	themes	with	
stakeholders.
These	six	steps	were	refined	and	extended	in	a	later	synthesis	by	
Viergever	et	al,89	oriented	primarily	to	public	health	and	health	sys‐
tems	research	in	low‐	and	middle‐income	countries.	They	added	two	
preliminary	 steps	 (understand	 the	 national	 and	 local	 context,	 and	
F I G U R E  3  Example	of	framework	for	
patient	and	lay	involvement	in	research	
priority‐setting,	reproduced	with	
permission	from	Pollock	et	al36
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decide	whether	a	comprehensive	approach	is	needed	at	all),	efforts	
to	include	the	voices	of	marginalized	groups,	and	included	a	follow‐
up	evaluation	(see	full	framework	in	Appendix	S1).89	More	recently,	
researchers	from	Zambia	published	a	similar	health	system‐oriented	
framework	based	on	a	systematic	analysis	of	previous	frameworks	
and	two	user	workshops.88
The	 UK‐based	 James	 Lind	 Alliance	 developed	 a	 framework	
for	 topic‐focused	 priority‐setting	 partnerships	 oriented	 mainly	
to	 the	design	of	new	clinical	 trials	 in	2008	and	updated	 in	2013	
(Figure	 3).36	 They	 emphasized	 five	 principles:	 transparency	 of	
process;	 balanced	 inclusion	 of	 patient,	 carer	 and	 clinician	 inter‐
ests	 and	perspectives;	 exclusion	of	non‐clinician	 researchers	 for	
voting	purposes	(they	may	be	involved	in	all	other	aspects	of	the	
process);	exclusion	of	those	with	significant	competing	interests,	
for	example	pharmaceutical	companies;	and	maintained	audit	trail.	
A	 similar	 framework,	 oriented	 to	 priority‐setting	 in	 comparative	
effectiveness	 research,	 was	 produced	 by	 PCORI	 in	 the	 United	
States.68
Pollock	et	al36	adapted	the	James	Lind	Alliance	methodology	
to	 increase	participation	by	a	potentially	 excluded	group	 (stroke	
patients	with	aphasia).	Modifications	included	visits	to	individuals'	
homes;	 visits	 to	patient	 advocacy	and	 support	groups;	provision	
of	materials	 in	multiple	formats	 including	easy‐read	and	aphasia‐
friendly;	assistance	with	responding	(eg,	scribing);	and	assistance	
with	access	to	venues.
Unique	among	our	data	set	was	a	Dutch	framework	describing	
what	the	authors	called	the	Dialogue	Model,	which	used	participa‐
tory	(and	explicitly	power‐sharing)	methods	to	set	research	priorities,	
including	an	early	consultation	phase	to	“enable	patients	to	develop	
their	own	voice	and	agenda	[and	prepare]	for	broader	collaboration	
with	other	stakeholder	groups”	(page	160).86
Whilst	 the	 James	 Lind	 Alliance	 drew	 on	 the	 principles	 of	
power‐sharing	developed	by	Oliver	et	al,44	critical	social	scientists	
have	 suggested	 that	 despite	 the	 democratic	 intentions	 of	 its	 ar‐
chitects,	priority‐setting	partnerships	do	not	necessarily	empower	
patients,	since	researchers	retain—and	may	choose	to	wield—the	
power	to	define	what	a	legitimate	research	question	is	and	how	to	
answer	it.96,97
3.4 | Study‐focused frameworks
Of	 19	 frameworks	 in	 this	 category	 (from	 UK,12,35,47‐52	 United	
States,70‐75	 Canada,79‐81	 Spain87	 and	 Southern	 Africa90),	 14	 were	
based	 on	 a	 more	 or	 less	 linear	 model	 of	 a	 clinical	 trial	 and	 pro‐
posed	how	patient	 and	 lay	 involvement	 could	 be	woven	 into	 it	 at	
every	 stage	 from	 writing	 the	 proposal	 to	 disseminating	 the	 find‐
ings.12,35,47,48,51,70,72,73,75,79‐81,87,90	 One	 framework	 focused	 on	 the	
phase	before	formal	ethical	approval	was	gained50	and	one	on	the	
involvement	of	patients	in	setting	clinical	outcomes.74	One	consid‐
ered	the	economic	costs	and	benefits	of	 lay	 involvement	 in	differ‐
ent	phases	of	a	clinical	trial71;	and	one	addressed	how	to	maintain	
recruitment	 to	 successive	 trials	 over	 time.49	 A	 framework	 for	 im‐
proving	patient	engagement	in	Alzheimer's	disease	trials	highlighted	
specific	challenges	with	this	target	population	and	offered	solutions	
based	on	a	literature	review.87
Most	studies	in	this	category	were	funded	by	bodies	that	spon‐
sor	clinical	trials	and/or	seek	to	ensure	patient	input	to	such	trials.	
These	include	the	UK	National	Institute	for	Health	Research	(NIHR)	
Research	Design	Service	(Figure	4),51	PCORI	in	United	States,70 and 
international	development	funders.90
All	publications	in	this	category	emphasized	that,	in	the	view	of	
the	authors,	patient	and	 lay	 input	 throughout	a	clinical	 trial	would	
make	 the	 trial	 more	 relevant,	 more	 appealing	 to	 potential	 partic‐
ipants,	 more	 likely	 to	 reach	 its	 target	 recruitment,	 more	 likely	 to	
retain	participants	and	more	likely	to	generate	and	disseminate	high‐
quality	research	knowledge.
Whilst	 study‐focused	 frameworks	 differed	 in	 detail,	 common	
features	 included	 the	need	 to:	 (a)	assess	and	understand	 the	 local	
context	 and	nature	of	 the	proposed	 study;	 (b)	 plan	 ahead	 and	 re‐
source	each	step	adequately;	 (c)	go	beyond	tokenism	(eg,	ensuring	
that	patient	 involvement	 is	more	 than	 “ticking	a	box”);	 (d)	 address	
inclusivity	 (eg,	 by	 developing	 research	 capacity	 in	 satellite	 clinics	
serving	 ethnically	 diverse	 sub‐populations);	 (e)	 address	 human	 as‐
pects	(building	relationships,	clarifying	roles,	communicating	clearly,	
establishing	trust	and	sharing	information);	and	(f)	develop	and	nur‐
ture	an	ongoing	relationship	with	lay	partners	(anticipating	and	tran‐
sitioning	to	the	next	trial).	Some	offered	tools	to	work	systematically	
through	procedural	and	process	aspects	of	patient	and	lay	involve‐
ment	(eg,	what	to	write	on	official	forms	and	where	to	submit	them).
One	 paper	 proposed	 a	 set	 of	 “ethical”	 questions	 to	 ask	 about	
user	 involvement	 in	 relation	 to	a	 clinical	 trial35:	Are	users	 fully	 in‐
formed	about	the	proposed	study?;	Are	they	able	to	opt	out?;	Are	
they	 well	 enough	 to	 participate?;	 Are	 they	 overcommitted	 with	
other	research?;	How	will	their	details	be	kept?;	Will	their	expenses	
be	met?;	Will	they	become	distressed	by	taking	part?;	and	Will	they	
receive	peer	supervision	and/or	peer	support?
Two	studies	(from	UK48	and	Canada80)	had	used	realist	methods	
to	explore	 the	 links	between	context,	mechanism	and	outcome	 in	
patient	involvement	activities	linked	to	clinical	trials;	an	example	is	
shown	in	the	Appendix	S1.	Both	found	that	effective,	non‐tokenistic	
involvement	of	lay	people	in	clinical	trials	depended	on	the	interac‐
tion	between	contextual	factors	(nature	of	the	research	field,	lead‐
ership	 by	 the	 principal	 investigator,	 a	 culture	 of	 involvement)	 and	
mechanisms	 (notably,	 a	 senior	member	of	 the	 team	 leading	on	 lay	
involvement,	nurturing	of	 interpersonal	 relationships	and	develop‐
ment	of	mutual	trust,	facilitation	and	feedback).48,80
Another	paper	proposed	an	economic	model	 for	estimating	 the	
financial	value	of	patient	involvement	in	the	clinical	development	of	
oncology	drugs.71	The	authors	used	an	economic	technique	(expected	
net	present	value)	for	assessing	cost	and	benefits	in	drug	development	
(based	on	five	key	drivers:	revenue,	costs,	time,	risk	and	intangibles).	
They	applied	this	in	a	novel	way	to	patient	engagement	in	the	research	
process.	They	found	that	more	patient	involvement	substantially	low‐
ers	the	chances	(and	hence	the	cost)	of	protocol	amendments	and	also	
improves	 the	 participant	 experience,	 leading	 to	 fewer	 withdrawals	
from	the	study	(again,	with	major	predicted	cost	savings).
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F I G U R E  4  Example	of	study‐focused	framework	for	patient	and	lay	involvement	in	research,	reproduced	with	permission	from	the	NIHR	
Research	Design	Service51
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Two	 recently	 published	 study‐focused	 frameworks	 included	
an	 additional	 dimension	 of	measuring	 the	 impact	 of	 such	 involve‐
ment.68,72	Dillon	et	al,73	for	example,	used	a	literature	review	along	
with	user	workshops	to	develop	the	Critical	Outcomes	of	Research	
Engagement	 (CORE)	 framework	shown	 in	Figure	5,	 through	which	
key	aspects	of	patient	and	 lay	 involvement	can	be	 tied	 to	specific	
and	measurable	outcomes	 (see	Appendix	S1	for	a	table	of	specific	
metrics).	For	example,	asking	patients	to	feed	back	on	the	wording	
of	questionnaire	items	(process)	would	be	expected	to	increase	the	
completion	rate	(outcome)	and	hence	the	robustness	of	the	findings	
(impact).
3.5 | Report‐focused frameworks
Four	frameworks,	all	 from	UK,	offered	a	checklist	for	critically	ap‐
praising	a	published	study	for	the	quality	and	comprehensiveness	of	
patient	and	lay	involvement.	Three	covered	primary	studies33‐35; and 
one	covered	systematic	 reviews.53	All	addressed	 (at	 least	 in	broad	
outline)	 the	 structure	of	 a	 clinical	 trial	 report	 (eg,	 rationale,	meth‐
odology,	findings,	discussion,	evaluation	or	reflection)	or	systematic	
review	equivalent.	Two	were	produced	by	the	GRIPP	team	as	part	of	
the	EQUATOR	network;	the	latest	version	is	the	34‐item	long‐form	
GRIPP‐2	checklist	(shown	in	short	form	in	Table	2).34	Report‐focused	
frameworks	 for	primary	 studies	assumed	 that	 the	 research	design	
was	a	clinical	trial;	they	addressed	the	same	elements	in	broadly	the	
same	way	as	study‐focused	frameworks,	but	did	so	retrospectively	
(as	a	quality	checklist)	rather	than	prospectively	(to	guide	activity).
3.6 | Partnership‐focused frameworks
Seventeen	 frameworks	 (from	 United	 States,10	 Canada,20,82 
Australia,31	 UK,27,54‐61	 the	 Netherlands84,85	 and	 Belgium91)	 were	
classified	as	predominantly	partnership‐focused,	 in	 that	 they	were	
explicitly	designed	to	optimize	collaborative	partnerships	between	
researchers	 and	 lay	 people	 or	 lay	 organizations	 and	measure	 key	
dimensions	 of	 partnership	 success—preferably	 quantitatively	 and	
reproducibly.	Most	such	frameworks	placed	particular	emphasis	on	
governance,	public	release	of	data	(transparency)	and	accountability.	
Details	of	some	exemplar	partnership‐focused	frameworks	are	listed	
in	the	Appendix	S1.
The	 James	 Lind	 Alliance	 (described	 above	 in	 the	 “Priority‐set‐
ting”	category	above)	was	one	of	the	first	groups	to	propose	some	
F I G U R E  5  Example	of	study‐focused	framework	for	measuring	the	impact	of	patient	and	lay	involvement	in	research,	reproduced	under	
Creative	Commons	licence	from	Dillon	et	al73
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core	 principles	 underpinning	 research	 partnerships	 with	 patients	
and	 the	public:	 transparency,	 balance,	 exclusion	of	 conflicts	of	 in‐
terest,	and	audit.46
Boote	 et	 al38	 in	 2006	 used	 an	 extensive	 Delphi	 process	 to	
generate	eight	principles	(including	agreed	roles,	reimbursement,	
respect	 and	 training),	 each	with	 an	 audit	 indicator,	 for	 support‐
ing	 researcher‐lay	partnerships	more	generally	 (see	Appendix	S1	
for	details).	These	early	 initiatives	are	typical	of	approaches	that	
seek	 to	deliver	what	Daniels	has	 termed	 “accountability	 for	 rea‐
sonableness”	in	the	public	sector—that	is,	demonstrating	a	system‐
atic,	transparent	and	auditable	process	through	which	citizens	and	
service	users	can	contribute	 to,	and	help	oversee,	 the	work	of	a	
public	body.98
A	 number	 of	 academic‐lay	 partnerships	 have	 produced	 simi‐
lar	 frameworks,	 typically	 as	 a	 result	 of	 hybrid	 funding	 from	aca‐
demic,	 service	 and	patient	organizations.31,41,55,59‐61,77,79,82,84,85,91 
Common	 themes	 in	 this	 category	 included	 governance	 mecha‐
nisms	including	formal	power‐sharing	arrangements	(eg,	co‐chair‐
ing);	good	leadership	and	project	management;	clear	and	effective	
communication	 (including	 commitment	 to	 listening	 and	 respond‐
ing);	 mechanisms	 to	 ensure	 inclusivity	 (eg,	 outreach,	 reimburse‐
ment);	 training	 and	 capacity‐building	 (of	 both	 researchers	 and	
lay	 partners);	 regular	 activities	 to	 maintain	 contact;	 promotion	
of	shared	values	and	collaborative	 learning	 (what	one	framework	
called	a	“participatory	culture”82);	and	metrics	for	measuring	pro‐
cesses	and	impact.
The	above	themes	featured	prominently,	 for	example,	 in	a	UK‐
based	 consortium's	 “UK	 PPI	 Standards	 for	 public	 involvement	 in	
research”	 (inclusive	 opportunities,	 working	 together,	 support	 and	
learning,	 communications,	 impact	 and	 governance),	 published	 in	
March	2018.27	These	six	standards	were	produced	by	a	partnership	
between	 NIHR,	 Health	 Research	 and	 Care	Wales,	 Chief	 Scientist	
Officer	Scotland	and	the	Public	Health	Agency	in	Northern	Ireland,	
and	based	on	extensive	engagement	work	with	almost	700	partici‐
pants	including	patients,	the	public	and	researchers.	Each	standard	
is	accompanied	by	a	set	of	auditable	metrics,	all	addressed	at	individ‐
ual,	team	and	organizational	level,	on	which	NIHR‐funded	research	
organizations	are	invited	to	report.	The	INVOLVE	principles	are	re‐
produced	in	Table	3,	and	the	standards	are	reproduced	in	full	in	the	
Appendix	S1.
3.7 | Evidence of framework use
The	only	dimension	of	the	CEPPP	tool	on	which	a	high	proportion	
of	frameworks	scored	poorly	was	usability	(which	we	interpreted	to	
include	 actual	 evidence	 of	 use).	 Power‐focused	 frameworks	 were	
rarely	used	directly,	but	they	informed	and	underpinned	subsequent	
work	 on	 more	 applied	 categories	 of	 framework.46,51,58	 Some	 but	
not	 all	 priority‐setting,46,78,85	 study‐focused79‐81	 and	 partnership‐
focused31,38,55,58,59,61,82,84	 frameworks	 went	 on	 to	 be	 used	 by	 the	
groups	that	developed	them,	but	very	few	had	evidence	of	adoption	
by	other	groups.	One	framework	was	promoted	by	the	UK	Health	
Technology	Assessment	programme	as	“best	practice.”38	The	most	
recent	 report‐focused	 framework	 (GRIPP234)	 is	 recommended	 by	
several	leading	journals,	though	few	currently	make	its	use	manda‐
tory.	Three	frameworks	that	were	developed	within	a	particular	clin‐
ical	field	(elderly	care,80	rheumatology59,84	and	addiction	services	for	
marginalized	groups79)	are	now	used	by	other	research	teams	in	the	
same	 field,	 dissemination	occurred	via	 conferences	and	 topic‐spe‐
cific	clinical	research	networks	(personal	communications	from	lead	
authors).
In	 only	 one	 example	 (Abelson	 et	 al's	 Public	 and	 Patient	
Engagement	Evaluation	Tool81),	the	authors,	who	are	actively	audit‐
ing	use	of	their	framework,	reported	widespread	use	of	their	public	
involvement	instrument	to	evaluate	lay	involvement	(personal	com‐
munication	 from	 lead	author).	A	search	of	 the	published	academic	
literature	using	Google	Scholar	identified	only	rare	instances	of	one	
research	group	describing	the	application	of	a	framework	developed	
by	 another	 group,92,99	 though	we	 acknowledge	 that	we	may	 have	
missed	other	examples.	Only	one	framework	in	our	sample	reported	
formal	usability	 testing.82	At	 the	time	of	writing,	 the	UK	PPI	stan‐
dards	are	being	piloted	for	usability	in	10	testbeds	and	49	additional	
organizations	 across	 the	 UK100;	 a	 revised	 set	 of	 standards	 is	 ex‐
pected	to	be	published	in	2019.
In	sum,	frameworks	to	guide	patient	and	lay	involvement	in	re‐
search	developed	in	one	setting	do	not	appear	to	have	transferred	
readily	to	other	settings,	except	when	they	have	been	oriented	to	a	
specific	clinical	field	and	actively	disseminated	within	that	field.
Our	 data	 set	 also	 revealed	 a	 number	 of	 examples	 of	 efforts	
to	 operationalize	 a	 theoretically	 derived	 framework	using	 some	
kind	of	practical	workshop.	For	example,	the	Public	Involvement	
Section and topic Item
1.	Aim Report	on	the	aim	of	PPI	(patient	and	public	involvement)	in	the	study
2.	Methods Provide	a	clear	description	of	the	methods	used	for	PPI	in	the	study
3.	Study	results Outcomes—report	the	results	of	PPI	in	the	study,	including	both	positive	
and	negative	outcomes
4.	Discussion	and	
conclusions
Outcomes—comment	on	the	extent	to	which	PPI	influenced	the	study	
overall.	Describe	positive	and	negative	effects
5.	Reflections/
critical	
perspective
Comment	critically	on	the	study,	reflecting	on	the	things	that	went	well	
and	those	that	did	not,	so	others	can	learn	from	this	experience
Reproduced	from	reference	34	under	Collective	Commons	Licence	4.0.
TA B L E  2  Example	of	report‐focused	
framework:	GRIPP2	short	form
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Impact	Assessment	Framework	 (PiiAF)58	was	developed	using	 a	
literature	review	and	Delphi	panel	to	formulate	draft	principles101 
and	a	series	of	facilitated	workshops	to	address	usability.37	Other	
examples	of	workshop	formats	included	De	Wit	et	al's84	“serious	
play”	workshop	 to	 surface	 and	 explore	 researchers'	 willingness	
to	 share	power	with	 lay	partners,	 and	Dillon	et	 al's73	 facilitated	
workshop	 to	 finalize	 and	operationalize	 their	Critical	Outcomes	
of	 Research	 Engagement	 (CORE)	metrics	 for	measuring	 the	 im‐
pact	 of	 lay	 involvement.	 These	 groups	 (and	 others	 in	 our	 data	
set31,85,91)	described	a	positive	process	characterized	by	produc‐
tive	conflict	which	 improved	stakeholder	engagement	and	part‐
nership	synergy.
3.8 | Co‐design phase
Following	our	 two	preliminary	development	workshops,	 the	 three	
co‐design	workshops	 involved	a	 total	of	30	participants	 (including	
people	who	identified	primarily	as	patients,	carers	and	service	users,	
those	 who	 worked	 in	 facilitation	 or	 advocacy	 roles,	 researchers,	
research	 managers	 and	 industry	 representatives).	 Each	 workshop	
unfolded	differently,	with	participants	drawing	on	the	resources	in	
different	ways.	The	workshop	resources	and	facilitator	notes	(avail‐
able	as	Appendix	S2)	appeared	flexible	and	enabled	the	generation	
of	widely	differing	frameworks	designed	for	different	purposes.	All	
the	workshops	were	positively	evaluated;	some	seemed	to	be	more	
successful	than	others	(related	to	the	maturity	of	the	group	and	the	
quality	 of	 facilitation).	 None	 of	 the	workshops,	 even	 those	work‐
ing	with	well‐established	 patient	 involvement	 groups,	 produced	 a	
definitive	framework,	which	suggests	that	a	frameworking	process	
is	 likely	 to	 require	a	 series	of	 facilitated	workshops,	not	a	one‐off	
event.	Additional	findings	from	the	workshop	study	(which	is	ongo‐
ing)	will	be	reported	in	a	subsequent	paper.
4  | DISCUSSION
4.1 | Summary of principal findings
This	 study,	which	 to	our	 knowledge	 is	 the	 first	 attempt	 at	 a	 com‐
prehensive	synthesis	of	frameworks	for	supporting	patient	and	lay	
involvement	in	health	research,	has	produced	four	main	findings.
First,	well	over	60	frameworks	already	exist,	many	though	not	all	
of	which	have	been	robustly	developed	using	both	theoretical	prin‐
ciples	and	extensive	patient	and	lay	involvement.
Second,	we	 have	 developed	 a	 new	 taxonomy	 of	 these	 frame‐
works—power‐focused,	 priority‐setting,	 study‐focused,	 report‐fo‐
cused	 and	partnership‐focused—based	on	 their	 primary	 focus	 and	
intended	purpose.
Third,	 we	 have	 ascertained	 that	 most	 published	 frameworks	
have	been	little	used	beyond	the	groups	that	developed	them	(with	
the	 exception	 of	 frameworks	 oriented	 to	 a	 particular	 clinical	 field	
and	disseminated	via	networks	within	that	field).
Finally,	we	have	refined	a	provisional	format	and	set	of	resources	
for	an	evidence‐based	“develop	your	own	framework”	workshop	to	
be	run	adaptively	by	researcher‐lay	partnerships.
Whilst	 the	 frameworks	 in	 our	 data	 set	were	 developed	 in	 dif‐
ferent	ways	and	for	diverse	reasons	and	use	cases,	 the	similarities	
among	them	were	as	striking	as	their	differences.	Almost	all	authors	
warned	 about	 the	 dangers	 of	 tokenism	 and	 tick‐box	 approaches;	
encouraged	efforts	to	extend	the	diversity	and	representativeness	
of	 patient	 and	 lay	 input;	 emphasized	 that	 democratic	 values	 and	
TA B L E  3  Example	of	partnership‐focused	framework:	the	INVOLVE	values	and	principles	framework
Values Summary principles Example of measurable impact
1.	Respect Researchers,	research	organizations	and	the	
public	respect	one	another's	roles	and	
perspectives
Public	members'	contributions	are	acknowledged,	for	example	as	
co‐applicants	in	research	applications,	as	authors	or	co‐authors	of	
publications,	or	as	presenters	or	co‐presenters	of	research	findings	(1e)
2.	Support Researchers,	research	organizations	and	the	
public	have	access	to	practical	and	organiza‐
tional	support	to	involve	and	be	involved
Public	members'	expenses	are	covered,	and	they	are	informed	in	advance	
if	payment	will	be	offered	for	their	time	(2d)
3.	Transparency Researchers,	research	organizations	and	the	
public	are	clear	and	open	about	the	aims	and	
scope	of	involvement	in	the	research
Clear	information	is	given	about	public	members'	role	and	what	has	been	
agreed;	information	is	given	about	the	time	period	and	type	of	
contribution	(eg,	partnership,	advisory	role,	reviewer)	(3b)
4.	Responsiveness Researchers	and	research	organizations	
actively	respond	to	the	input	of	public	
members	involved	in	research
Public	members	are	listened	to	and	changes	are	made	to	the	research	as	a	
result	of	the	insights,	advice	and	guidance	received;	where	changes	are	
not	made,	reasons	are	explained	(4b)
5.	Fairness	of	
opportunity
Researchers	and	research	organizations	
ensure	that	public	involvement	in	research	is	
open	to	individuals	and	communities	without	
discrimination
The	diversity	required	for	the	research	is	considered	and	an	effort	is	
made	to	involve	those	who	reflect	that	diversity	(5a)
6.	Accountability Researchers,	research	organizations	and	the	
public	are	accountable	for	their	involvement	
in	research	and	to	the	people	affected	by	the	
research
At	the	end	of	a	research	study,	all	those	who	have	worked	together	
actively	reflect	on	the	public	involvement	in	the	project	and	assess	the	
learning	and	how	it	has	gone;	everyone	is	given	an	opportunity	to	feed	
back	about	their	experience	of	involvement	(6d)
Reproduced	from	reference	27	with	permission	of	INVOLVE.	Numbers	in	column	3	refer	to	paragraphs	in	INVOLVE	document.
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principles	must	be	underpinned	by	leadership,	good	governance	and	
attention	to	training	and	practicalities;	and	recommended	ongoing	
evaluation	to	feed	into	organizational	learning	and	quality	improve‐
ment.	The	empirical	component	of	our	study	illustrated	that	a	com‐
mon	 set	 of	 evidence‐based	 resources	 can,	 when	 used	 to	 support	
facilitated	design,	produce	different	kinds	of	framework	to	suit	the	
needs	of	different	groups.
4.2 | Comparison with other studies
Four	 previous	 “framework	 of	 frameworks”	 publications	 offered	 a	
taxonomy	 of	 published	 approaches	 to	 patient	 and	 lay	 involvement	
in	health	research,	though	each	took	a	narrower	focus	than	our	own	
review.	 In	 an	early	non‐systematic	 review	 (written	when	only	 six	of	
the	frameworks	in	our	sample	had	been	published),	Savory	arranged	
previous	literature	broadly	along	two	axes:	focus	of	involvement	(pa‐
tient,	carer,	group,	 interested	 layperson,	general	public)	and	purpose	
of	participation	(“on,”	“with,”	“by”	and	“led	by”	lay	people).64	Fransman	
explored	various	theoretical	discourses	used	to	analyse	public	engage‐
ment	 in	 research	 (not	 limited	 to	 health).63	 Hughes	 and	 Duffy	 used	
concept	analysis	 to	consider	how	power‐sharing	had	been	theorized	
in	previous	public	 involvement	 frameworks.62	Boivin	et	al83	 summa‐
rized	and	critiqued	evaluation	tools	for	patient	and	lay	involvement	in	
research.
The	 emerging	 literature	 on	 the	 use	 of	 practical	 workshops	 in	
knowledge	creation	helps	explain	why	our	 focus	on	building	one's	
own	framework	appeared	to	be	more	successful	than	inviting	groups	
to	 use	 off‐the‐shelf	 frameworks.	 This	 literature	 includes	 reviews	
of	 approaches	 to	 co‐creation	 of	 knowledge102	 and	 the	 sociology	
of	design,103	and	(more	specifically	relevant	to	our	empirical	work)	
a	 recent	 theorization	of	 “collective	making.”29	 In	 the	 last	of	 these,	
Langley	et	al	propose	three	domains	of	influence	when	people	from	
different	sectors	come	together	to	engage	in	creative	play:
•	 influence	on	participants	(creative	play	levels	hierarchies,	reduces	
jargon,	 gives	 voice,	 sparks	 ideas,	 inspires	 motivation,	 helps	 ar‐
ticulate	complex	 ideas	and	concepts,	 and	may	have	 therapeutic	
value);
•	 influence	on	knowledge	 (creative	play	shares	knowledge	in	many	
different	forms,	creates	new	knowledge,	blends	and	synthesizes	
knowledge,	 and	 retains	a	pragmatic	 focus	on	using	knowledge);	
and
•	 influence	 on	 the	 process of implementation	 (the	 intervention	
generated	 through	 creative	 play	 is	 “owned”	 by	 end‐users;	 the	
intervention	 incorporates	 research,	 experiential	 and	 contextual	
knowledge	and	comes	with	the	testimony	of	end‐users	who	were	
involved	in	the	making;	it	includes	a	“boundary	object”	in	physical	
or	visual	 form	that	acts	 to	engage	others	beyond	the	co‐design	
group;	and	it	typically	includes	“core”	and	“adaptable”	elements).
The	 shift	 in	our	 focus	 from	 identifying	published	 frameworks	 to	
supporting	 local	co‐design	of	 frameworks	 reflects	an	emerging	phil‐
osophical	shift	in	the	way	knowledge	is	conceptualized:	from	a	highly	
objective	view	of	knowledge	 (positivism,	which	views	knowledge	as	
“facts”	 that	are	empirically	derived	and	to	a	 large	extent	context‐in‐
dependent)	and	a	more	subjective	view	 (interpretivism,	which	views	
knowledge	 as	 socially	 constructed	 and	 perspectival)	 to	 a	 hands‐on	
view	of	knowledge	(known	as	performative	and	defined	as	something	
that	 is	brought	 into	being	 in	and	 through	human	action).102	 In	other	
words,	actively	building	a	framework	may	be	more	effective	and	en‐
during	 than	attempting	 to	 apply	 someone	else's	 framework.	Van	de	
Ven	 and	 Johnson104	 explain	 how	 the	 principles	 and	 philosophy	 of	
pragmatism	 (attending	primarily	 to	 the	practical	 and	context‐depen‐
dent	use	to	which	the	outputs	of	practical	work	will	be	put)	can	aid	a	
performative	approach	 to	 collaborative	knowledge	creation:	 “By	ex‐
ploiting	multiple	perspectives,	 the	robust	features	of	reality	become	
salient	and	can	be	distinguished	from	those	features	that	are	merely	a	
function	of	one	particular	view	or	model”	(page	810).
Ours	is	not	the	first	study	to	grapple	with	the	tension	between	
an	 academic	 ideal	 and	a	 local,	 pragmatic	 solution.	Deborah	Ghate	
recently	described	an	attempt	to	co‐produce	a	parenting	programme	
that	was	both	 “evidence‐based”	 (ie,	 drawing	on	 the	 research	 liter‐
ature,	which	 in	 this	 case	was	 characterized	 by	 intensive	 interven‐
tions	that	were	difficult	to	replicate	and	prohibitively	expensive)	and	
“home‐grown”	(ie,	co‐produced	by	local	practitioners	and	the	groups	
they	sought	to	serve,	taking	account	of	contextual	realities	and	re‐
source	 constraints).105	 Published	 research	 evidence	 was	 used	 to	
develop	a	sophisticated	theory	of	change	that	was	fed	into	local	ac‐
tivities	to	produce	what	Ghate	called	“evidence‐supported	design.”
4.3 | Strengths and limitations
To	our	knowledge,	this	 is	the	most	comprehensive	and	systematic	
summary	of	patient	and	lay	involvement	frameworks	yet	published.	
The	literature	search	was	extensive	and	used	multiple	methods	(in‐
cluding	database	searching,	hand	searching	and	citation	tracking)	to	
amass	an	extensive	primary	data	set.	Through	detailed	data	extrac‐
tion	 and	 theoretical	 analysis,	we	 have	 produced	 a	 new	 taxonomy	
into	which	future	studies	can	be	classified—and	which	has	the	po‐
tential	to	be	extended	if	other	groups	develop	new	approaches	to	
exploring	 the	 field.	This	 is	also	 the	 first	 systematic	 review	on	 this	
topic	to	have	gone	beyond	an	academic	synthesis:	we	produced,	and	
empirically	 tested,	a	set	of	 resources	 intended	for	use	 in	practical	
workshops,	allowing	different	 researcher‐lay	partnerships	 to	draw	
on	them	in	different	ways	through	evidence‐informed	serious	play.
One	 limitation	of	 this	 review	 is	 that	 few	primary	 studies	were	
based	 in	 low‐	 or	middle‐income	 settings.	 A	 reviewer	 of	 an	 earlier	
draft	of	this	paper	suggested	that	not	all	countries	or	settings	have	a	
strong	culture	of	patient	involvement	in	research,	so	frameworks	or	
framework‐building	activities	 that	 implicitly	assume	such	a	culture	
may	have	limited	success.
Another	 key	 limitation	of	 this	 study	 is	 that	 the	empirical	 com‐
ponent	reported	here	was	preliminary.	We	tested	the	practical	re‐
sources	on	only	three	researcher‐lay	partnerships,	all	of	which	were	
linked	to	the	University	of	Oxford	and	did	not	represent	the	poten‐
tial	 range	 of	 diversity	 of	 such	 partnerships.	Whilst	we	 believe	we	
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have	demonstrated	proof	of	 concept	 for	our	 “co‐design	 your	own	
framework”	approach,	we	 invite	other	groups	 to	explore	 their	use	
of	our	workshop	resources	and	facilitator	guides	in	a	wider	range	of	
target	groups	and	settings.	We	have	made	these	resources	available	
free	 for	download	 from	the	Health	Expectations	website	 to	 those	
using	them	in	non‐profit	initiatives.
5  | CONCLUSION
This	study	has	shown	that	numerous	published	frameworks	for	sup‐
porting	 and	 evaluating	 patient	 and	 public	 involvement	 in	 research	
already	 exist.	 They	 have	 different	 provenances,	 intended	purposes,	
strengths	and	limitations.	But	being	evidence‐based	and	theoretically	
informed	is	no	guarantee	that	a	framework	will	be	used.	A	single,	one‐
size‐fits‐all	 framework	may	be	 less	useful	 than	a	 range	of	 resources	
that	can	be	adapted	and	combined	 in	a	 locally	generated	co‐design	
activity.
We	suggest	that	those	who	seek	to	develop	or	strengthen	the	
patient	 or	 lay	 involvement	 in	 their	 own	 research	 use	 a	 three‐step	
process.	 First,	 explore	 the	 published	 examples	 described	 in	 this	
paper	 and	 the	 Appendix	 S1.	 Depending	 on	 context	 and	 intended	
use	case,	a	framework	may	be	found	that	is	fit	for	purpose—perhaps	
with	some	adaptation.	In	the	absence	of	such	a	framework,	down‐
load	and	study	 the	 facilitator	guide	and	evidence‐based	 resources	
and	prompts,	which	are	based	on	the	findings	of	this	review.	Finally,	
work	with	patient	collaborators	and	(ideally)	professional	facilitators	
to	plan	and	deliver	a	 series	of	 co‐design	workshops	 to	generate	a	
locally	relevant	and	locally	owned	framework.
ACKNOWLEDG EMENTS
We	thank	the	patients,	lay	people,	researchers	and	research	support	
staff	 who	 attended	 the	 co‐design	 workshops,	 without	 whom	 this	
study	would	not	have	been	possible.	We	also	 thank	 the	 authors	of	
primary	studies,	many	of	whom	helpfully	provided	additional	contex‐
tual	data	on	their	study	(included	where	relevant	in	the	spreadsheet	
in	the	Appendix	S3).	We	thank	Robert	Macfarlane	for	help	with	hand	
searching.
CONFLIC T OF INTERE S T
None declared.
E THIC S APPROVAL AND CONSENT TO PARTICIPATE
This	 study	 is	part	of	 the	 “Partnerships	 for	Health,	Wealth	and	
Innovation”	research	stream	of	the	Oxford	Biomedical	Research	
Centre	which	received	ethics	clearance	through	the	University	
of	 Oxford	 Central	 University	 Research	 Ethics	 Committee	
(R51801/RE001).	 Written	 consent	 was	 obtained	 from	 patient	
participants.
TR ANSPARENC Y DECL AR ATION
TG	 (the	manuscript's	 guarantor)	 affirms	 that	 the	manuscript	 is	 an	
honest,	 accurate	 and	 transparent	 account	 of	 the	 study	 being	 re‐
ported;	that	no	important	aspects	of	the	study	have	been	omitted;	
and	 that	 any	discrepancies	 from	 the	 study	 as	 planned	 (and,	 if	 rel‐
evant,	registered)	have	been	explained.
ORCID
Trisha Greenhalgh  https://orcid.org/0000‐0003‐2369‐8088 
R E FE R E N C E S
	 1.	 Wicks	P,	Richards	T,	Denegri	S,	Godlee	F.	Patients'	roles	and	rights	
in	research.	BMJ.	2018;362:k3193.
	 2.	 Ward	 PR,	 Thompson	 J,	 Barber	 R,	 et	 al.	 Critical	 perspectives	 on	
‘consumer	involvement’	in	health	research:	epistemological	disso‐
nance	and	the	know‐do	gap.	J Sociol.	2010;46(1):63‐82.
	 3.	 Edelman	 N,	 Barron	 D.	 Evaluation	 of	 public	 involvement	 in	 re‐
search:	 time	 for	 a	 major	 re‐think?	 J Health Serv Res Policy. 
2016;21(3):209‐211.
	 4.	 Madden	M,	 Speed	 ES.	 Beware	 Zombies	 and	 Unicorns:	 towards	
critical	patient	and	public	involvement	in	health	research	in	a	neo‐
liberal	context.	Front Sociol. 2017;2:7.
	 5.	 Oliver	 S,	 Liabo	 K,	 Stewart	 R,	 Rees	 R.	 Public	 involvement	 in	 re‐
search:	 making	 sense	 of	 the	 diversity.	 J Health Serv Res Policy. 
2015;20(1):45‐51.
	 6.	 Domecq	JP,	Prutsky	G,	Elraiyah	T,	et	al.	Patient	engagement	in	re‐
search:	a	systematic	review.	BMC Health Serv Res.	2014;14(1):89.
	 7.	 Brett	 J,	 Staniszewska	 S,	 Mockford	 C,	 Seers	 K,	 Herron‐Marx	
S,	 Bayliss	 H.	 The PIRICOM Study: A Systematic Review of the 
Conceptualisation, Measurement, Impact and Outcomes of Patients 
and Public Involvement in Health and Social Care Research.	Coventry:	
University	of	Warwick;	2010.
	 8.	 Purtell	 RA,	Wyatt	 KM.	Measuring	 something	 real	 and	 useful	 in	
consumer	 involvement	 in	 health	 and	 social	 care	 research.	 Int J 
Consum Stud.	2011;35(6):605‐608.
	 9.	 Shimmin	C,	Wittmeier	KD,	Lavoie	JG,	Wicklund	ED,	Sibley	KM.	
Moving	 towards	 a	 more	 inclusive	 patient	 and	 public	 involve‐
ment	 in	 health	 research	 paradigm:	 the	 incorporation	 of	 a	
trauma‐informed	 intersectional	 analysis.	 BMC Health Serv Res. 
2017;17(1):539.
	 10.	 Esmail	L,	Moore	E,	Rein	A.	Evaluating	patient	and	stakeholder	en‐
gagement	in	research:	moving	from	theory	to	practice.	J Comp Eff 
Res.	2015;4(2):133‐145.
	 11.	 Crocker	JC,	Ricci‐Cabello	I,	Parker	A,	et	al.	Impact	of	patient	and	
public	 involvement	 on	 enrolment	 and	 retention	 in	 clinical	 trials:	
systematic	review	and	meta‐analysis.	BMJ.	2018;363:k4738.
	 12.	 Bagley	HJ,	Short	H,	Harman	NL,	et	al.	A	patient	and	public	involve‐
ment	(PPI)	toolkit	for	meaningful	and	flexible	involvement	in	clini‐
cal	trials–a	work	in	progress.	Res Involv Engagem.	2016;2(1):15.
	 13.	 Gibbons	M,	Limoges	C,	Nowotny	H,	Schwartzman	S,	Scott	P,	Trow	
M.	The New Production of Knowledge: The Dynamics of Science and 
Research in Contemporary Societies.	London,	UK:	Sage;	1994.
	 14.	 Hanney	S,	Kuruvilla	 S,	 Soper	B,	Mays	N.	Who	needs	what	 from	
a	 national	 health	 research	 system:	 lessons	 from	 reforms	 to	 the	
English	Department	of	Health's	R&D	system.	Health Res Policy Syst. 
2010;8:11.
	 15.	 Horobin	A.	Going	the	extra	mile–creating	a	co‐operative	model	for	
supporting	patient	and	public	involvement	in	research.	Res Involv 
Engagem.	2016;2(1):9.
     |  15GREENHALGH Et AL.
	 16.	 Selby	 JV,	 Beal	 AC,	 Frank	 L.	 The	 Patient‐Centered	 Outcomes	
Research	Institute	(PCORI)	national	priorities	for	research	and	ini‐
tial	research	agenda.	JAMA.	2012;307(15):1583‐1584.
	 17.	 Denegri	S.	Going the Extra Mile: Improving the Nation's Health and 
Wellbeing Through Public Involvement in Research.	London:	National	
Institute	 for	 Health	 Research;	 2015.	 https://www.rds‐yh.nihr.
ac.uk/wp‐content/uploads/2015/06/Going‐the‐Extra‐Mile‐Final.
pdf.	Accessed	March	29,	2019.
	 18.	 National	Institute	for	Health	Research.	The Public as our Partners. 
NIHR CCF Highlights from 2015/16.	London:	NIHR;	2016.	https://
www.nihr.ac.uk/about‐us/how‐we‐are‐managed/managing‐cen‐
tres/nihr‐central‐commissioning‐facility/Documents/CCF_
PPIEreport15_16SHORT.pdf.	Accessed	March	29,	2019.
	 19.	 Walshe	K,	McKee	M,	Groenewegen	P,	et	al.	Reshaping	the	agenda	
of	 the	 European	 Commission	 for	 the	 health	 systems	 and	 policy	
research	 in	Europe	within	Horizon	2020.	Epidemiol Biostat Public 
Health.	2013;10(2):e8951‐2.
	 20.	 Canadian	 Institutes	 of	 Health	 Research.	 Strategy for Patient‐
Oriented Research: Patient Engagement Framework.	 ON:	 CIHR;	
2017.	http://www.cihr‐irsc.gc.ca/e/48413.html.	Accessed	August	
28,	2017.
	 21.	 Ovseiko	PV,	Heitmueller	A,	Allen	P,	et	al.	 Improving	accountabil‐
ity	through	alignment:	the	role	of	academic	health	science	centres	
and	networks	in	England.	BMC Health Serv Res.	2014;14:24.
	 22.	 Greenhalgh	T,	Ovseiko	PV,	Fahy	N,	et	al.	Maximising	value	 from	
a	 United	 Kingdom	 Biomedical	 Research	 Centre:	 study	 protocol.	
Health Res Policy Syst.	2017;15(1):70.
	 23.	 Centre	of	Excellence	on	Partnership	with	Patients	and	the	Public.	
CEPPP Evaluation Toolkit.	 Montreal,	 QC:	 CEPPP;	 2017.	 https://
nouveau.ceppp.ca/en/evaluation‐toolkik/	 Accessed	 August	 28,	
2017.
	 24.	 Steuli	 J,	 Vayena	 E.	 The Promising Revolution of Participant‐Led 
Research in Rare Neurological Diseases; Potential Benefits and 
Pitfalls.	 Epileptologie;	 2016.	 https://www.researchgate.net/
profile/Juerg_Streuli/publication/293769190_The_Promising_
Revolution_of_Participant‐Led_Research_in_Rare_Neurological_
Diseases/links/56bb11cb08ae0a6bc9560d68.pdf.	Accessed	June	
7,	2017.
	 25.	 Faulkner	 A,	 NSUN	 National	 Involvement	 Team.	 Involvement for 
Influence.	4Pi	National	Involvement	Partnership	for	Mental	Health;	
2016.	 http://www.nsun.org.uk/assets/downloadableFiles/4Pi‐
NationalInvolvementStandardsFullReport20152.pdf.	 Accessed	
August	28,	2017.
	 26.	 Staley	K.	Exploring Impact: Public Involvement in NHS, Public Health 
and Social Care Research.	Eastleigh:	INVOLVE;	2009.	http://www.
invo.org.uk/wpcontent/uploads/2011/11/Involve_Exploring_
Impactfinal28.10.09.pdf.	Accessed	August	28,	2017.
	 27.	 National	 Institute	 for	Health	Research.	Draft Standards for Public 
Involvement in Research.	Southampton:	NIHR;	2017.	https://sites.
google.com/nihr.ac.uk/pi‐standards/home.	Accessed	 January	 11,	
2019.
	 28.	 Boell	SK,	Cecez‐Kecmanovic	D.	A	hermeneutic	approach	for	con‐
ducting	literature	reviews	and	literature	searches.	Commun Assoc 
Inf Syst.	2014;34(1):257‐286.
	 29.	 Langley	J,	Wolstenholme	D,	Cooke	J.	'Collective	making'	as	knowl‐
edge	mobilisation:	the	contribution	of	participatory	design	in	the	
co‐creation	 of	 knowledge	 in	 healthcare.	 BMC Health Serv Res. 
2018;18(1):585.
	 30.	 Greenhalgh	T,	Thorne	S,	Malterud	K.	Time	to	challenge	the	spu‐
rious	 hierarchy	 of	 systematic	 over	 narrative	 reviews?	 Eur J Clin 
Invest.	2018;48(6):e12931.
	 31.	 Miller	CL,	Mott	K,	Cousins	M,	et	al.	Integrating	consumer	engage‐
ment	 in	 health	 and	 medical	 research–an	 Australian	 framework.	
Health Res Policy Syst.	2017;15(1):9.
	 32.	 Greenhalgh	T,	Peacock	R.	Effectiveness	and	efficiency	of	search	
methods	in	systematic	reviews	of	complex	evidence:	audit	of	pri‐
mary	sources.	BMJ.	2005;331(7524):1064‐1065.
	 33.	 Staniszewska	 S,	 Brett	 J,	 Mockford	 C,	 Barber	 R.	 The	 GRIPP	
checklist:	 strengthening	 the	 quality	 of	 patient	 and	 public	 in‐
volvement	reporting	in	research.	 Int J Technol Assess Health Care. 
2011;27(4):391‐399.
	 34.	 Staniszewska	S,	Brett	J,	Simera	 I,	et	al.	GRIPP2	reporting	check‐
lists:	tools	to	improve	reporting	of	patient	and	public	involvement	
in	research.	Res Involv Engagem.	2017;3(1):13.
	 35.	 Wright	D,	Foster	C,	Amir	Z,	Elliott	J,	Wilson	R.	Critical	appraisal	
guidelines	for	assessing	the	quality	and	impact	of	user	involvement	
in	research.	Health Expect.	2010;13(4):359‐368.
	 36.	 Pollock	A,	George	BS,	Fenton	M,	Crowe	S,	Firkins	L.	Development	
of	 a	 new	model	 to	 engage	 patients	 and	 clinicians	 in	 setting	 re‐
search	priorities.	J Health Serv Res Policy.	2014;19(1):12‐18.
	 37.	 Gibson	A,	Welsman	J,	Britten	N.	Evaluating	patient	and	public	in‐
volvement	in	health	research:	from	theoretical	model	to	practical	
workshop.	Health Expect.	2017;20(5):826‐835.
	 38.	 Boote	J,	Barber	R,	Cooper	C.	Principles	and	indicators	of	success‐
ful	 consumer	 involvement	 in	 NHS	 research:	 results	 of	 a	 Delphi	
study	and	subgroup	analysis.	Health Policy.	2006;75(3):280‐297.
	 39.	 Oliver	SR,	Rees	RW,	Clarke‐Jones	L,	et	al.	A	multidimensional	con‐
ceptual	framework	for	analysing	public	involvement	in	health	ser‐
vices	research.	Health Expect.	2008;11(1):72‐84.
	 40.	 Gibson	A,	Britten	N,	Lynch	J.	Theoretical	directions	for	an	eman‐
cipatory	 concept	 of	 patient	 and	 public	 involvement.	 Health. 
2012;16(5):531‐547.
	 41.	 Gradinger	F,	Britten	N,	Wyatt	K,	et	al.	Values	associated	with	pub‐
lic	involvement	in	health	and	social	care	research:	a	narrative	re‐
view. Health Expect.	2015;18(5):661‐675.
	 42.	 Morrow	E,	Ross	F,	Grocott	P,	Bennett	J.	A	model	and	measure	for	
quality	service	user	involvement	in	health	research.	 Int J Consum 
Stud.	2010;34(5):532‐539.
	 43.	 Prainsack	B.	Understanding	participation:	 the	 ‘citizen	science’	of	
genetics.	 In:	Prainsack	B,	Schicktanz	S,	Werner‐Felmayer	G,	eds.	
Genetics as Social Practice: Transdisciplinary Views on Science and 
Culture.	London:	Routledge;	2016.
	 44.	 Oliver	 S,	 Clarke‐Jones	 L,	 Rees	 R,	 et	 al.	 Involving	 consumers	 in	
research	 and	 development	 agenda	 setting	 for	 the	 NHS:	 de‐
veloping	 an	 evidence‐based	 approach.	 Health Technol Assess. 
2004;8(15):1‐148.
	 45.	 Corbie‐Smith	 G,	 Wynn	 M,	 Richmond	 A,	 et	 al.	 Stakeholder‐
driven,	 consensus	 development	 methods	 to	 design	 an	 ethi‐
cal	 framework	 and	 guidelines	 for	 engaged	 research.	 PloS One. 
2018;13(6):e0199451.
	 46.	 Cowan	 K,	 Oliver	 S.	 The James Lind Alliance Guidebook. 
Southampton:	National	 Institute	for	Health	Research	Evaluation,	
Trials	and	Studies	Coordinating	Centre;	2013.
	 47.	 Buck	D,	Gamble	C,	Dudley	L,	et	al.	From	plans	to	actions	in	patient	
and	 public	 involvement:	 qualitative	 study	 of	 documented	 plans	
and	the	accounts	of	researchers	and	patients	sampled	from	a	co‐
hort	of	clinical	trials.	BMJ Open.	2014;4(12):e006400.
	 48.	 Evans	D,	Coad	J,	Cottrell	K,	et	al.	Public	involvement	in	research:	
assessing	impact	through	a	realist	evaluation.	Health Serv Deliv Res. 
2014;2:36.
	 49.	 Heaven	 A,	 Brown	 L,	 Foster	 M,	 Clegg	 A.	 Keeping	 it	 credible	 in	
cohort	 multiple	 Randomised	 Controlled	 Trials:	 the	 Community	
Ageing	Research	75+(CARE	75+)	study	model	of	patient	and	public	
involvement	and	engagement.	Res Involv Engagem.	2016;2(1):30.
	 50.	 Pandya‐Wood	R,	Barron	DS,	Elliott	J.	A	framework	for	public	 in‐
volvement	at	the	design	stage	of	NHS	health	and	social	care	re‐
search:	 time	 to	develop	ethically	conscious	standards.	Res Involv 
Engagem.	2017;3(1):6.
16  |     GREENHALGH Et AL.
	 51.	 National	 Institute	 for	 Health	 Research.	 Patient and Public 
Involvement in Health and Social Care Research: A Handbook for 
Researchers.	Leeds:	NIHR.	https://www.nihr.ac.uk/about‐us/CCF/
funding/how‐we‐can‐help‐you/RDS‐PPI‐Handbook‐2014‐v8‐
FINAL.pdf.	Accessed	November	16,	2017.
	 52.	 Evans	B,	Bedson	E,	Bell	P,	et	al.	 Involving	 service	users	 in	 trials:	
developing	a	standard	operating	procedure.	Trials.	2013;14(1):219.
	 53.	 Pollock	A,	 Campbell	 PE,	 Struthers	 C,	 et	 al.	Development	 of	 the	
ACTIVE	 framework	 to	 describe	 stakeholder	 involvement	 in	 sys‐
tematic	reviews.	J Health Serv Res Policy.	2018;Epub	ahead	of	print.
	 54.	 INVOLVE.	 Public Involvement in Research: Values and Principles 
Framework.	 Eastleigh:	 INVOLVE;	 2016.	 http://www.invo.org.
uk/posttypepublication/public‐involvement‐in‐researchval‐
ues‐and‐principles‐framework/.	Accessed	November	10,	2017.
	 55.	 Jordan	M,	 Rowley	 E,	Morriss	 R,	Manning	 N.	 An	 analysis	 of	 the	
Research	 Team‐Service	User	 relationship	 from	 the	 Service	User	
perspective:	 a	 consideration	 of	 ‘The	Three	Rs’	 (Roles,	 Relations,	
and	Responsibilities)	for	healthcare	research	organisations.	Health 
Expect.	2015;18(6):2693‐2703.
	 56.	 Moule	P,	Davies	R.	A	devolved	model	for	public	involvement	in	the	
field	of	mental	health	research:	case	study	learning.	Health Expect. 
2016;19(6):1302‐1311.
	 57.	 Pollard	 K,	 Donskoy	 A‐L,	 Moule	 P,	 Donald	 C,	 Lima	 M,	 Rice	 C.	
Developing	 and	 evaluating	 guidelines	 for	 patient	 and	 pub‐
lic	 involvement	 (PPI)	 in	 research.	 Int J Health Care Qual Assur. 
2015;28(2):141‐155.
	 58.	 Popay	 J,	 Collins	 M.	 The Public Involvement Impact Assessment 
Framework Guidance.	 Lancaster:	 University	 of	 Lancaster;	 2014.	
www.piaf.org.uk.	Accessed	August	28,	2017.
	 59.	 Hewlett	S,	Wit	Md,	Richards	P,	et	al.	Patients	and	professionals	as	
research	partners:	challenges,	practicalities,	and	benefits.	Arthritis 
Rheum.	2006;55(4):676‐680.
	 60.	 Baines	 RL,	 Regan	 de	 Bere	 S.	 Optimizing	 patient	 and	 public	 in‐
volvement	 (PPI):	 Identifying	 its	 “essential”	and	“desirable”	princi‐
ples	using	a	systematic	review	and	modified	Delphi	methodology.	
Health Expect.	2018;21(1):327‐335.
	 61.	 Brown	 LJ,	 Dickinson	 T,	 Smith	 S,	 et	 al.	 Openness,	 inclusion	 and	
transparency	 in	 the	 practice	 of	 public	 involvement	 in	 research:	
A	reflective	exercise	to	develop	best	practice	recommendations.	
Health Expect.	2018;21(2):441‐447.
	 62.	 Hughes	M,	Duffy	C.	Public	involvement	in	health	and	social	sciences	
research:	a	concept	analysis.	Health Expect.	2018;21(6):1183‐1190.
	 63.	 Fransman	 J.	Charting	 a	 course	 to	 an	 emerging	 field	of	 'research	
engagement	 studies':	 a	 conceptual	 meta‐synthesis.	 Res All. 
2018;2(2):185‐229.
	 64.	 Savory	C.	Patient	and	public	involvement	in	translative	healthcare	
research.	Clin Govern.	2010;15(3):191‐199.
	 65.	 Belone	L,	Lucero	JE,	Duran	B,	et	al.	Community‐based	participa‐
tory	research	conceptual	model:	Community	partner	consultation	
and	face	validity.	Qual Health Res.	2016;26(1):117‐135.
	 66.	 Powell	MP,	Young	AJ,	Kim	H.	A	 journey	 in	capacity	building:	 re‐
visiting	 the	 mullins	 framework	 for	 meaningfully	 engaging	 pa‐
tients	in	patient	centered	outcomes	research.	Front Public Health. 
2018;6:343.
	 67.	 Ceasar	 J,	 Peters‐Lawrence	 MH,	 Mitchell	 V,	 Powell‐Wiley	 TM.	
The	communication,	awareness,	relationships	and	empowerment	
(CARE)	model:	an	effective	tool	for	engaging	urban	communities	
in	community‐based	participatory	research.	Int J Environ Res Public 
Health.	2017;14(11):1422.
	 68.	 Patient	 Centered	 Outcomes	 Research	 Institute.	 Generation and 
Prioritization of Topics for Funding Announcements.	 Washington,	
DC:	 PCORI;	 2014.	 https://www.pcori.org/research‐results/how‐
we‐select‐research‐topics/generation‐and‐prioritization‐top‐
ics‐funding‐4.	Accessed	November	16,	2017.
	 69.	 Castillo	 WC,	 Hendricks	 J.	 Engaging	 hispanic	 caregivers	 in	 re‐
search:	a	framework	to	design	culturally	sensitive	approaches	for	
engagement	in	patient‐centered	outcomes	research.	Value Health. 
2015;18(7):A815.
	 70.	 Shippee	ND,	Domecq	Garces	JP,	Prutsky	Lopez	GJ,	et	al.	Patient	
and	service	user	engagement	in	research:	a	systematic	review	and	
synthesized	framework.	Health Expect.	2015;18(5):1151‐1166.
	 71.	 Levitan	 B,	 Getz	 K,	 Eisenstein	 EL,	 et	 al.	 Assessing	 the	 financial	
value	of	patient	engagement:	a	quantitative	approach	from	CTTI's	
Patient	 Groups	 and	 Clinical	 Trials	 project.	 Ther Innov Regul Sci. 
2018;52(2):220‐229.
	 72.	 Deverka	PA,	Lavallee	DC,	Desai	PJ,	et	al.	Stakeholder	participation	
in	comparative	effectiveness	 research:	defining	a	 framework	 for	
effective	engagement.	J Comp Eff Res.	2012;1:181‐194.
	 73.	 Dillon	EC,	Tuzzio	L,	Madrid	S,	Olden	H,	Greenlee	RT.	Measuring	
the	impact	of	patient‐engaged	research:	how	a	methods	workshop	
identified	critical	outcomes	of	research	engagement.	J Patient Cent 
Res Rev.	2017;4(4):237‐246.
	 74.	 Wilson	H,	Dashiell‐Aje	E,	Anatchkova	M,	et	al.	Beyond	study	par‐
ticipants:	 a	 framework	 for	 engaging	 patients	 in	 the	 selection	 or	
development	of	clinical	outcome	assessments	 for	evaluating	 the	
benefits	of	treatment	 in	medical	product	development.	Qual Life 
Res.	2018;27(1):5‐16.
	 75.	 Deverka	PA,	Bangs	R,	Kreizenbeck	K,	et	al.	A	new	framework	for	
patient	 engagement	 in	 cancer	 clinical	 trials	 cooperative	 group	
studies.	J Natil Cancer Inst.	2018;110(6):553‐559.
	 76.	 Kwon	SC,	Tandon	SD,	Islam	N,	Riley	L,	Trinh‐Shevrin	C.	Applying	
a	 community‐based	 participatory	 research	 framework	 to	 pa‐
tient	 and	 family	 engagement	 in	 the	 development	 of	 patient‐
centered	 outcomes	 research	 and	 practice.	 Transl Behav Med. 
2018;8(5):683‐691.
	 77.	 Warren	NT,	Gaudino	JA	Jr,	Likumahuwa‐Ackman	S,	et	al.	Building	
meaningful	 patient	 engagement	 in	 research:	 case	 study	 from	
ADVANCE	clinical	data	research	network.	Med Care.	2018;56(Suppl	
10	Suppl	1):S58‐S63.
	 78.	 Lomas	 J,	 Fulop	N,	Gagnon	D,	Allen	P.	On	being	 a	 good	 listener:	
setting	priorities	for	applied	health	services	research.	Milbank Q. 
2003;81(3):363‐388.
	 79.	 Pakhale	S,	Kaur	T,	Florence	K,	et	al.	The	Ottawa	Citizen	Engagement	
and	Action	Model	 (OCEAM):	 a	 citizen	 engagement	 strategy	 op‐
erationalized	through	the	participatory	research	in	Ottawa,	man‐
agement	and	point‐of‐care	of	tobacco	(PROMPT)	Study.	Res Involv 
Engagem.	2016;2(1):20.
	 80.	 McNeil	H,	Elliott	J,	Huson	K,	et	al.	Engaging	older	adults	in	health‐
care	research	and	planning:	a	realist	synthesis.	Res Involv Engagem. 
2016;2(1):10.
	 81.	 Abelson	J,	Wagner	F,	DeJean	D,	et	al.	Public	and	patient	involve‐
ment	in	health	technology	assessment:	a	framework	for	action.	Int 
J Technol Assess Health Care.	2016;32(4):256‐264.
	 82.	 Abelson	 J,	 Li	 K,	Wilson	 G,	 Shields	 K,	 Schneider	 C,	 Boesveld	 S.	
Supporting	quality	public	and	patient	engagement	 in	health	sys‐
tem	 organizations:	 development	 and	 usability	 testing	 of	 the	
public	 and	 patient	 engagement	 evaluation	 tool.	 Health Expect. 
2015;19(4):817‐827.
	 83.	 Boivin	 A,	 L'Espérance	 A,	 Gauvin	 F‐P,	 et	 al.	 Patient	 and	 pub‐
lic	 engagement	 in	 research	 and	 health	 system	 decision	 mak‐
ing:	 a	 systematic	 review	 of	 evaluation	 tools.	 Health Expect. 
2018;21(6):1075‐1084.
	 84.	 De	Wit	M,	Elberse	JE,	Broerse	JE,	Abma	TA.	Do	not	forget	the	pro‐
fessional–the	value	of	the	FIRST	model	for	guiding	the	structural	
involvement	of	patients	in	rheumatology	research.	Health Expect. 
2015;18(4):489‐503.
	 85.	 PatientPartner	 Project.	 Ethical Principles of Partnership Between 
Researchers and the Public.	Brussels:	European	Commission;	2011.	
     |  17GREENHALGH Et AL.
http://www.patientpartner‐europe.eu.	 Accessed	 October	 11,	
2017.
	 86.	 Abma	TA,	Broerse	JE.	Patient	participation	as	dialogue:	setting	re‐
search	agendas.	Health Expect.	2010;13(2):160‐173.
	 87.	 Boada	M,	Santos‐Santos	MA,	Rodriguez‐Gomez	O,	et	al.	Patient	
engagement:	the	Fundacio	ACE	framework	for	improving	recruit‐
ment	and	 retention	 in	Alzheimer's	disease	 research.	J Alzheimers 
Dis.	2018;62(3):1079‐1090.
	 88.	 Kapiriri	L,	Chanda‐Kapata	P.	The	quest	 for	a	 framework	 for	sus‐
tainable	and	institutionalised	priority‐setting	for	health	research	in	
a	low‐resource	setting:	the	case	of	Zambia.	Health Res Policy Syst. 
2018;16(1):11.
	 89.	 Viergever	RF,	Olifson	S,	Ghaffar	A,	Terry	RF.	A	checklist	for	health	
research	priority	setting:	nine	common	themes	of	good	practice.	
Health Res Policy Syst.	2010;8(1):36.
	 90.	 Musesengwa	 R,	 Chimbari	 MJ,	 Mukaratirwa	 S.	 A	 framework	 for	
community	 and	 stakeholder	 engagement:	 experiences	 from	 a	
multicenter	study	in	Southern	Africa.	J Empir Res Hum Res Ethics. 
2018;13(4):323‐332.
	 91.	 Patient	 Focused	 Medicines	 Development.	 Patient Engagement 
Quality Guidance.	 Brussels:	 PFMD;	 2018.	 http://patientfocused‐
medicine.org/peqg/patient‐engagement‐quality‐guidance.pdf.	
Accessed	August	12,	2018.
	 92.	 Collins	M,	 Long	R,	 Page	A,	 Popay	 J,	 Lobban	 F.	Using	 the	 Public	
Involvement	Impact	Assessment	Framework	to	assess	the	impact	
of	public	involvement	in	a	mental	health	research	context:	a	reflec‐
tive	case	study.	Health Expect.	2018;21(6):950‐963.
	 93.	 Arnstein	 SR.	 A	 ladder	 of	 citizen	 participation.	 J Am Inst Plann. 
1969;35(4):216‐224.
	 94.	 Mullen	P,	Murray‐Sykes	K,	Kearns	WE.	Community	Health	Council	
representation	 on	 planning	 teams:	 a	 question	 of	 politics?	Public 
Health.	1984;98(3):143‐151.
	 95.	 Nowotny	H,	 Scott	 P,	Gibbons	M.	Re‐Thinking Science: Knowledge 
and the Public in an Age of Uncertainty.	 Cambridge:	 Polity	 Press;	
2001.
	 96.	 Madden	M,	Morley	R.	Exploring	the	challenge	of	health	research	
priority	 setting	 in	 partnership:	 reflections	 on	 the	 methodology	
used	 by	 the	 James	 Lind	Alliance	 Pressure	Ulcer	 Priority	 Setting	
Partnership.	Res Involv Engagem.	2016;2(1):12.
	 97.	 Snow	R,	Crocker	J,	Crowe	S.	Missed	opportunities	 for	 impact	 in	
patient	and	carer	involvement:	a	mixed	methods	case	study	of	re‐
search	priority	setting.	Res Involv Engagem.	2015;1(1):7.
	 98.	 Daniels	N.	Accountability	 for	 reasonableness:	 Establishing	 a	 fair	
process	 for	priority	 setting	 is	easier	 than	agreeing	on	principles.	
BMJ.	2000;321(7272):1300.
	 99.	 Stocks	SJ,	Giles	SJ,	Cheraghi‐Sohi	S,	Campbell	SM.	Application	of	
a	tool	for	the	evaluation	of	public	and	patient	involvement	in	re‐
search.	BMJ Open.	2015;5(3):e006390.
	100.	 Anonymous.	 Test Bed and Freestyle Projects.	 National	 Standards	
for	 Public	 Involvement	 in	 Research;	 2019.	 https://sites.google.
com/nihr.ac.uk/pi‐standards/test‐beds?authuser=0.	 Accessed	
February	2,	2019.
	101.	 Snape	D,	Kirkham	J,	Preston	 J,	 et	 al.	Exploring	areas	of	 consen‐
sus	 and	 conflict	 around	 values	 underpinning	 public	 involvement	
in	health	and	social	care	 research:	a	modified	Delphi	study.	BMJ 
Open.	2014;4(1):e004217.
	102.	 Greenhalgh	T,	Jackson	C,	Shaw	S,	Janamain	T.	Achieving	research	
impact	through	co‐creation	 in	community‐based	health	services:	
literature	review	and	case	study.	Milbank Q.	2016;94(2):392‐429.
	103.	 Lupton	 D.	 Towards	 design	 sociology.	 Sociol Compass. 
2018;12(1):e12546.
	104.	 Van	de	Ven	AH,	Johnson	PE.	Knowledge	for	theory	and	practice.	
Acad Manage Rev.	2006;31(4):802‐821.
	105.	 Ghate	D.	Developing	 theories	 of	 change	 for	 social	 programmes:	
co‐producing	evidence‐supported	quality	 improvement.	Palgrave 
Commun.	2018;4(1):90.
SUPPORTING INFORMATION
Additional	 supporting	 information	 may	 be	 found	 online	 in	 the	
Supporting	Information	section	at	the	end	of	the	article.	  
How to cite this article:	Greenhalgh	T,	Hinton	L,	Finlay	T,	et	
al.	Frameworks	for	supporting	patient	and	public	involvement	
in	research:	Systematic	review	and	co‐design	pilot.	Health 
Expect. 2019;00:1–17. https://doi.org/10.1111/hex.12888
